000813 德展健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.263-7.054-0.3931.582-0.880
总资产报酬率 ROA (%)-1.207-6.778-0.3821.507-0.820
投入资产回报率 ROIC (%)-1.225-6.919-0.3901.565-0.868

边际利润分析
销售毛利率 (%)37.10856.15564.12858.73555.486
营业利润率 (%)-47.120-105.676-9.10716.106-20.815
息税前利润/营业总收入 (%)-80.494-109.529-23.5263.387-31.629
净利润/营业总收入 (%)-52.798-106.330-9.05110.890-26.882

收益指标分析
经营活动净收益/利润总额(%)78.07438.29522.81536.407-7.227
价值变动净收益/利润总额(%)2.0426.61045.04498.131-15.853
营业外收支净额/利润总额(%)0.5810.2593.7021.9761.867

偿债能力分析
流动比率 (X)15.89516.48430.49736.40911.821
速动比率 (X)14.85915.53728.69634.27411.072
资产负债率 (%)5.7046.1472.9112.5506.909
带息债务/全部投入资本 (%)2.4892.467-0.039-0.0780.391
股东权益/带息债务 (%)3,896.4523,928.007-255,015.756-127,036.02425,175.138
股东权益/负债合计 (%)1,682.7401,547.7903,330.2483,819.2371,349.603
利息保障倍数 (X)2.43230.6121.672-0.2603.036

营运能力分析
应收账款周转天数 (天)321.029216.177148.889172.701205.925
存货周转天数 (天)286.746357.395436.115401.493390.241